JCL CLINICAL SERVICES LIMITED
Company number 14500820 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
JCL CLINICAL SERVICES LIMITED - Analysis Report
Company Number: 14500820
Analysis Date: 2025-07-29 12:43 UTC
Financial Health Assessment of JCL CLINICAL SERVICES LIMITED
1. Financial Health Score: D
Explanation:
The company shows clear signs of financial distress, primarily due to significant negative net current assets and negative shareholders’ funds. While it is still active and supported by its directors, the current financial "vital signs" indicate liquidity challenges and an imbalance between short-term liabilities and assets. The score D reflects a concern level that requires immediate attention to avoid worsening financial health.
2. Key Vital Signs and Interpretation
| Metric | 2024 Value (£) | Interpretation |
|---|---|---|
| Fixed Assets | 8,475 | Modest asset base, mainly intangible and tangible assets acquired recently. Indicates investment in operational infrastructure. |
| Current Assets | 7,923 | Consists of cash (£1,807) and debtors (£6,116). Low cash buffer relative to liabilities. |
| Current Liabilities | 54,421 | High short-term debts, including significant amounts owed to group undertakings (£51,947). This is a major liquidity risk ("symptom of distress"). |
| Net Current Assets | -46,498 | Negative working capital – means the company cannot cover its short-term obligations with its current assets; a critical red flag. |
| Total Assets Less Current Liabilities | -38,023 | Overall asset coverage is negative, indicating liabilities exceed assets. |
| Shareholders’ Funds (Equity) | -38,123 | Negative equity signals accumulated losses or funding deficits; puts company’s solvency into question. |
| Turnover & Profitability | Not disclosed | Absence of profit and loss account limits insight into operational profitability and cash flow generation. |
| Going Concern Status | Supported by directors | Directors confirm ongoing support, which is vital for survival given current financials. |
3. Diagnosis: What the Financial Data Reveals
Liquidity Crisis: The company’s current liabilities vastly exceed its current assets, causing a working capital deficit. This is akin to a patient whose vital signs show severely low blood pressure — a sign of impaired immediate function. The company might struggle to meet short-term obligations without additional inflows or support.
Negative Equity: Shareholders' funds are negative, indicating the company has accumulated losses or has taken on liabilities beyond its asset base. This can be compared to a patient with depleted reserves, signaling long-term sustainability concerns.
Dependence on Director Support: The directors have confirmed continued support, which currently acts like an external life-support system keeping the company operational. Without this, the company risks insolvency or formal restructuring.
Early Stage Business: Incorporated in late 2022, the company is still in its infancy. Negative equity and working capital deficits are not uncommon in startups but must be managed carefully.
Limited Financial Transparency: Lack of profit and loss details restricts a full health check on revenue generation and expense control. The company should increase transparency to better diagnose operational health.
4. Recommendations: Steps to Improve Financial Wellness
Improve Liquidity Management:
- Accelerate collection of debtors to boost cash reserves.
- Negotiate extended payment terms with creditors, especially group undertakings, to reduce immediate cash outflows.
- Explore short-term financing options or director loans to ease liquidity pressure.
Cost Control and Revenue Growth:
- Implement strict expense management to avoid further erosion of reserves.
- Develop strategies to increase turnover and cash inflows, such as expanding client base or services offered.
Equity Injection or Debt Restructuring:
- Consider additional capital contributions from shareholders or parent entities to restore positive equity and strengthen the balance sheet.
- Restructure existing debts to manageable terms to reduce financial strain.
Enhanced Financial Reporting:
- Prepare and disclose profit and loss accounts to gain clearer insights into operational performance and enable timely interventions.
- Monitor key financial ratios regularly (e.g., liquidity ratios, gearing, and profitability margins) for early detection of issues.
Contingency Planning:
- Develop a turnaround plan including scenario analysis to prepare for adverse developments.
- Engage professional advisors early if financial distress deepens.
Medical Analogy Summary
JCL Clinical Services Limited currently exhibits "symptoms" such as negative working capital and equity, akin to a patient with dangerously low vital signs indicating distress. The company is on "life support" through director backing, but without prompt intervention—improving liquidity, controlling costs, and strengthening equity—there is a risk of financial collapse. Early and decisive action is critical to restore financial "health" and ensure sustainable operations.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.